Anticoagulante lúpico: análisis clínico y de laboratorio de 45 pacientes
Cüellar, Francisco; Vásquez, Gloria M; Alvarez, Leonor; Maya, Luz M; Murillo, Magda L; Mondragón, María C.
Acta méd. colomb
; 15(5): 298-302, sept.-oct. 1990. tab
Artículo en Español | LILACS | ID: lil-183158
Documentos relacionados
16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends.
Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE).
A toggle switch linking coagulation and innate immunity in antiphospholipid antibody syndrome.
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Antiphospholipid antibodies and cerebrovascular thrombosis in the pediatric population: Few answers to many questions.
A novel presentation of childhood systemic lupus erythematosus in a 6-year-old child.
Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch.
Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE.
Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.